FRONT MED-LAUSANNE 润色咨询

Frontiers in Medicine

出版年份：暂无数据 年文章数：5853 投稿命中率： 开通期刊会员，数据随心看

出版周期：暂无数据 自引率：暂无数据 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2164985, encodeId=887d2164985f4, content=是真的慢啊，一个多月初审审查，现在还没分配编辑，希望遇到个负责的，快点推进, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210908/5e1db7f0e5fe40b1aee34c6524b692af/ddf26fe993ca45ebaaeddde2fc3c64b7.jpg, createdBy=86005206116, createdName=赏你一丈红, createdTime=Thu Oct 26 09:19:08 CST 2023, time=2023-10-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1084023, encodeId=c1ac1084023c6, content=审稿速度:6.0 | 投稿命中率:25.0 | 版面费用:2950.0<br>偏重的研究方向：老年护理<br>经验分享：2021.7.14投稿，11.18更换编辑，12.5修回（4位审稿人：一位endorsed，一位reject，一位大修，一位小修），12.21修改稿上传，3位endorsed，1位reject，12.24接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5692110322, createdName=1521f88033m, createdTime=Fri Dec 24 20:46:18 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158054, encodeId=0e172158054db, content=为啥我投了之后 送审2个专家 第1个直接拒稿 第2个给了意见 返修后同意 又送审第3个专家 修稿后同意 现在又显示第4个外审专家啊 啥时候是个头哦，有前辈碰到过吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10fa6477215, createdName=ms8000000901131773, createdTime=Sat Sep 16 22:12:30 CST 2023, time=2023-09-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1055376, encodeId=829210553e6e4, content=请问一下这个杂志要找几个审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210927/5a9862d841f546cc85e85b47339bb199/f0e9ff7632ac408aac70eca0d475545a.jpg, createdBy=c0472529402, createdName=124fad42m35暂无昵称, createdTime=Mon Sep 27 15:07:53 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095352, encodeId=d013209535251, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：肺内科<br>经验分享：还在投稿，期待后续, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c98c5209159, createdName=1475736bm89暂无昵称, createdTime=Sat Oct 22 11:49:11 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223091, encodeId=432e122309135, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：临床<br>经验分享：挺快的，两个审稿人，一个接收，一个大修，修改中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f138180290, createdName=ms5000000814037832, createdTime=Sun May 29 07:53:58 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242200, encodeId=39f512422006d, content=偏重的研究方向：急危重症<br>经验分享：如果临床文章还纠结预警的话有点装了，说白了，大部分人根本就看不明白临床文章好坏跟错误，都是别人说好那就好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/yuhpYSG8zXWk7duFmickGZKMEsQE40icza3PyJ9XhHTI9Y5WmMdd8NzMNBiajBiaqcCCufuVhjErdtcMBGTuxP2OeQ/132, createdBy=01c72032081, createdName=形而上学, createdTime=Wed Aug 31 08:02:36 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236183, encodeId=018d123618327, content=审稿速度:24.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤<br>经验分享：一个多月了，还没有分配编辑，还让推荐编辑，推荐了半个月了还是没有分配编辑，你们也这么慢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da711654246, createdName=实验小达人, createdTime=Tue Aug 02 17:18:19 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235778, encodeId=c17e1235e7860, content=1个月了还没有分配编辑正常嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba715436134, createdName=ms1000001601271803, createdTime=Sun Jul 31 16:14:20 CST 2022, time=2022-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080458, encodeId=37a41080458a2, content=这个杂志是JCR Q1分区的。值得投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f4d1979640, createdName=毛教授, createdTime=Wed Dec 15 22:26:37 CST 2021, time=2021-12-15, status=1, ipAttribution=)]
    2023-10-26 赏你一丈红 来自湖北省

    是真的慢啊，一个多月初审审查，现在还没分配编辑，希望遇到个负责的，快点推进

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2164985, encodeId=887d2164985f4, content=是真的慢啊，一个多月初审审查，现在还没分配编辑，希望遇到个负责的，快点推进, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210908/5e1db7f0e5fe40b1aee34c6524b692af/ddf26fe993ca45ebaaeddde2fc3c64b7.jpg, createdBy=86005206116, createdName=赏你一丈红, createdTime=Thu Oct 26 09:19:08 CST 2023, time=2023-10-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1084023, encodeId=c1ac1084023c6, content=审稿速度:6.0 | 投稿命中率:25.0 | 版面费用:2950.0<br>偏重的研究方向：老年护理<br>经验分享：2021.7.14投稿，11.18更换编辑，12.5修回（4位审稿人：一位endorsed，一位reject，一位大修，一位小修），12.21修改稿上传，3位endorsed，1位reject，12.24接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5692110322, createdName=1521f88033m, createdTime=Fri Dec 24 20:46:18 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158054, encodeId=0e172158054db, content=为啥我投了之后 送审2个专家 第1个直接拒稿 第2个给了意见 返修后同意 又送审第3个专家 修稿后同意 现在又显示第4个外审专家啊 啥时候是个头哦，有前辈碰到过吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10fa6477215, createdName=ms8000000901131773, createdTime=Sat Sep 16 22:12:30 CST 2023, time=2023-09-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1055376, encodeId=829210553e6e4, content=请问一下这个杂志要找几个审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210927/5a9862d841f546cc85e85b47339bb199/f0e9ff7632ac408aac70eca0d475545a.jpg, createdBy=c0472529402, createdName=124fad42m35暂无昵称, createdTime=Mon Sep 27 15:07:53 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095352, encodeId=d013209535251, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：肺内科<br>经验分享：还在投稿，期待后续, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c98c5209159, createdName=1475736bm89暂无昵称, createdTime=Sat Oct 22 11:49:11 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223091, encodeId=432e122309135, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：临床<br>经验分享：挺快的，两个审稿人，一个接收，一个大修，修改中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f138180290, createdName=ms5000000814037832, createdTime=Sun May 29 07:53:58 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242200, encodeId=39f512422006d, content=偏重的研究方向：急危重症<br>经验分享：如果临床文章还纠结预警的话有点装了，说白了，大部分人根本就看不明白临床文章好坏跟错误，都是别人说好那就好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/yuhpYSG8zXWk7duFmickGZKMEsQE40icza3PyJ9XhHTI9Y5WmMdd8NzMNBiajBiaqcCCufuVhjErdtcMBGTuxP2OeQ/132, createdBy=01c72032081, createdName=形而上学, createdTime=Wed Aug 31 08:02:36 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236183, encodeId=018d123618327, content=审稿速度:24.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤<br>经验分享：一个多月了，还没有分配编辑，还让推荐编辑，推荐了半个月了还是没有分配编辑，你们也这么慢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da711654246, createdName=实验小达人, createdTime=Tue Aug 02 17:18:19 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235778, encodeId=c17e1235e7860, content=1个月了还没有分配编辑正常嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba715436134, createdName=ms1000001601271803, createdTime=Sun Jul 31 16:14:20 CST 2022, time=2022-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080458, encodeId=37a41080458a2, content=这个杂志是JCR Q1分区的。值得投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f4d1979640, createdName=毛教授, createdTime=Wed Dec 15 22:26:37 CST 2021, time=2021-12-15, status=1, ipAttribution=)]
    2021-12-24 1521f88033m

    审稿速度:6.0 | 投稿命中率:25.0 | 版面费用:2950.0
    偏重的研究方向：老年护理
    经验分享：2021.7.14投稿，11.18更换编辑，12.5修回（4位审稿人：一位endorsed，一位reject，一位大修，一位小修），12.21修改稿上传，3位endorsed，1位reject，12.24接收。

    4

    展开4条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2164985, encodeId=887d2164985f4, content=是真的慢啊，一个多月初审审查，现在还没分配编辑，希望遇到个负责的，快点推进, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210908/5e1db7f0e5fe40b1aee34c6524b692af/ddf26fe993ca45ebaaeddde2fc3c64b7.jpg, createdBy=86005206116, createdName=赏你一丈红, createdTime=Thu Oct 26 09:19:08 CST 2023, time=2023-10-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1084023, encodeId=c1ac1084023c6, content=审稿速度:6.0 | 投稿命中率:25.0 | 版面费用:2950.0<br>偏重的研究方向：老年护理<br>经验分享：2021.7.14投稿，11.18更换编辑，12.5修回（4位审稿人：一位endorsed，一位reject，一位大修，一位小修），12.21修改稿上传，3位endorsed，1位reject，12.24接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5692110322, createdName=1521f88033m, createdTime=Fri Dec 24 20:46:18 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158054, encodeId=0e172158054db, content=为啥我投了之后 送审2个专家 第1个直接拒稿 第2个给了意见 返修后同意 又送审第3个专家 修稿后同意 现在又显示第4个外审专家啊 啥时候是个头哦，有前辈碰到过吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10fa6477215, createdName=ms8000000901131773, createdTime=Sat Sep 16 22:12:30 CST 2023, time=2023-09-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1055376, encodeId=829210553e6e4, content=请问一下这个杂志要找几个审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210927/5a9862d841f546cc85e85b47339bb199/f0e9ff7632ac408aac70eca0d475545a.jpg, createdBy=c0472529402, createdName=124fad42m35暂无昵称, createdTime=Mon Sep 27 15:07:53 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095352, encodeId=d013209535251, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：肺内科<br>经验分享：还在投稿，期待后续, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c98c5209159, createdName=1475736bm89暂无昵称, createdTime=Sat Oct 22 11:49:11 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223091, encodeId=432e122309135, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：临床<br>经验分享：挺快的，两个审稿人，一个接收，一个大修，修改中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f138180290, createdName=ms5000000814037832, createdTime=Sun May 29 07:53:58 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242200, encodeId=39f512422006d, content=偏重的研究方向：急危重症<br>经验分享：如果临床文章还纠结预警的话有点装了，说白了，大部分人根本就看不明白临床文章好坏跟错误，都是别人说好那就好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/yuhpYSG8zXWk7duFmickGZKMEsQE40icza3PyJ9XhHTI9Y5WmMdd8NzMNBiajBiaqcCCufuVhjErdtcMBGTuxP2OeQ/132, createdBy=01c72032081, createdName=形而上学, createdTime=Wed Aug 31 08:02:36 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236183, encodeId=018d123618327, content=审稿速度:24.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤<br>经验分享：一个多月了，还没有分配编辑，还让推荐编辑，推荐了半个月了还是没有分配编辑，你们也这么慢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da711654246, createdName=实验小达人, createdTime=Tue Aug 02 17:18:19 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235778, encodeId=c17e1235e7860, content=1个月了还没有分配编辑正常嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba715436134, createdName=ms1000001601271803, createdTime=Sun Jul 31 16:14:20 CST 2022, time=2022-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080458, encodeId=37a41080458a2, content=这个杂志是JCR Q1分区的。值得投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f4d1979640, createdName=毛教授, createdTime=Wed Dec 15 22:26:37 CST 2021, time=2021-12-15, status=1, ipAttribution=)]
    2023-09-16 ms8000000901131773 来自江西省

    为啥我投了之后 送审2个专家 第1个直接拒稿 第2个给了意见 返修后同意 又送审第3个专家 修稿后同意 现在又显示第4个外审专家啊 啥时候是个头哦，有前辈碰到过吗

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2164985, encodeId=887d2164985f4, content=是真的慢啊，一个多月初审审查，现在还没分配编辑，希望遇到个负责的，快点推进, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210908/5e1db7f0e5fe40b1aee34c6524b692af/ddf26fe993ca45ebaaeddde2fc3c64b7.jpg, createdBy=86005206116, createdName=赏你一丈红, createdTime=Thu Oct 26 09:19:08 CST 2023, time=2023-10-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1084023, encodeId=c1ac1084023c6, content=审稿速度:6.0 | 投稿命中率:25.0 | 版面费用:2950.0<br>偏重的研究方向：老年护理<br>经验分享：2021.7.14投稿，11.18更换编辑，12.5修回（4位审稿人：一位endorsed，一位reject，一位大修，一位小修），12.21修改稿上传，3位endorsed，1位reject，12.24接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5692110322, createdName=1521f88033m, createdTime=Fri Dec 24 20:46:18 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158054, encodeId=0e172158054db, content=为啥我投了之后 送审2个专家 第1个直接拒稿 第2个给了意见 返修后同意 又送审第3个专家 修稿后同意 现在又显示第4个外审专家啊 啥时候是个头哦，有前辈碰到过吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10fa6477215, createdName=ms8000000901131773, createdTime=Sat Sep 16 22:12:30 CST 2023, time=2023-09-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1055376, encodeId=829210553e6e4, content=请问一下这个杂志要找几个审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210927/5a9862d841f546cc85e85b47339bb199/f0e9ff7632ac408aac70eca0d475545a.jpg, createdBy=c0472529402, createdName=124fad42m35暂无昵称, createdTime=Mon Sep 27 15:07:53 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095352, encodeId=d013209535251, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：肺内科<br>经验分享：还在投稿，期待后续, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c98c5209159, createdName=1475736bm89暂无昵称, createdTime=Sat Oct 22 11:49:11 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223091, encodeId=432e122309135, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：临床<br>经验分享：挺快的，两个审稿人，一个接收，一个大修，修改中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f138180290, createdName=ms5000000814037832, createdTime=Sun May 29 07:53:58 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242200, encodeId=39f512422006d, content=偏重的研究方向：急危重症<br>经验分享：如果临床文章还纠结预警的话有点装了，说白了，大部分人根本就看不明白临床文章好坏跟错误，都是别人说好那就好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/yuhpYSG8zXWk7duFmickGZKMEsQE40icza3PyJ9XhHTI9Y5WmMdd8NzMNBiajBiaqcCCufuVhjErdtcMBGTuxP2OeQ/132, createdBy=01c72032081, createdName=形而上学, createdTime=Wed Aug 31 08:02:36 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236183, encodeId=018d123618327, content=审稿速度:24.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤<br>经验分享：一个多月了，还没有分配编辑，还让推荐编辑，推荐了半个月了还是没有分配编辑，你们也这么慢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da711654246, createdName=实验小达人, createdTime=Tue Aug 02 17:18:19 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235778, encodeId=c17e1235e7860, content=1个月了还没有分配编辑正常嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba715436134, createdName=ms1000001601271803, createdTime=Sun Jul 31 16:14:20 CST 2022, time=2022-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080458, encodeId=37a41080458a2, content=这个杂志是JCR Q1分区的。值得投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f4d1979640, createdName=毛教授, createdTime=Wed Dec 15 22:26:37 CST 2021, time=2021-12-15, status=1, ipAttribution=)]
    2021-09-27 124fad42m35暂无昵称

    请问一下这个杂志要找几个审稿人啊

    8

    展开8条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2164985, encodeId=887d2164985f4, content=是真的慢啊，一个多月初审审查，现在还没分配编辑，希望遇到个负责的，快点推进, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210908/5e1db7f0e5fe40b1aee34c6524b692af/ddf26fe993ca45ebaaeddde2fc3c64b7.jpg, createdBy=86005206116, createdName=赏你一丈红, createdTime=Thu Oct 26 09:19:08 CST 2023, time=2023-10-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1084023, encodeId=c1ac1084023c6, content=审稿速度:6.0 | 投稿命中率:25.0 | 版面费用:2950.0<br>偏重的研究方向：老年护理<br>经验分享：2021.7.14投稿，11.18更换编辑，12.5修回（4位审稿人：一位endorsed，一位reject，一位大修，一位小修），12.21修改稿上传，3位endorsed，1位reject，12.24接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5692110322, createdName=1521f88033m, createdTime=Fri Dec 24 20:46:18 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158054, encodeId=0e172158054db, content=为啥我投了之后 送审2个专家 第1个直接拒稿 第2个给了意见 返修后同意 又送审第3个专家 修稿后同意 现在又显示第4个外审专家啊 啥时候是个头哦，有前辈碰到过吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10fa6477215, createdName=ms8000000901131773, createdTime=Sat Sep 16 22:12:30 CST 2023, time=2023-09-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1055376, encodeId=829210553e6e4, content=请问一下这个杂志要找几个审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210927/5a9862d841f546cc85e85b47339bb199/f0e9ff7632ac408aac70eca0d475545a.jpg, createdBy=c0472529402, createdName=124fad42m35暂无昵称, createdTime=Mon Sep 27 15:07:53 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095352, encodeId=d013209535251, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：肺内科<br>经验分享：还在投稿，期待后续, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c98c5209159, createdName=1475736bm89暂无昵称, createdTime=Sat Oct 22 11:49:11 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223091, encodeId=432e122309135, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：临床<br>经验分享：挺快的，两个审稿人，一个接收，一个大修，修改中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f138180290, createdName=ms5000000814037832, createdTime=Sun May 29 07:53:58 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242200, encodeId=39f512422006d, content=偏重的研究方向：急危重症<br>经验分享：如果临床文章还纠结预警的话有点装了，说白了，大部分人根本就看不明白临床文章好坏跟错误，都是别人说好那就好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/yuhpYSG8zXWk7duFmickGZKMEsQE40icza3PyJ9XhHTI9Y5WmMdd8NzMNBiajBiaqcCCufuVhjErdtcMBGTuxP2OeQ/132, createdBy=01c72032081, createdName=形而上学, createdTime=Wed Aug 31 08:02:36 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236183, encodeId=018d123618327, content=审稿速度:24.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤<br>经验分享：一个多月了，还没有分配编辑，还让推荐编辑，推荐了半个月了还是没有分配编辑，你们也这么慢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da711654246, createdName=实验小达人, createdTime=Tue Aug 02 17:18:19 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235778, encodeId=c17e1235e7860, content=1个月了还没有分配编辑正常嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba715436134, createdName=ms1000001601271803, createdTime=Sun Jul 31 16:14:20 CST 2022, time=2022-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080458, encodeId=37a41080458a2, content=这个杂志是JCR Q1分区的。值得投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f4d1979640, createdName=毛教授, createdTime=Wed Dec 15 22:26:37 CST 2021, time=2021-12-15, status=1, ipAttribution=)]
    2022-10-22 1475736bm89暂无昵称

    审稿速度:1.0 | 投稿命中率:75.0
    偏重的研究方向：肺内科
    经验分享：还在投稿，期待后续

    4

    展开4条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2164985, encodeId=887d2164985f4, content=是真的慢啊，一个多月初审审查，现在还没分配编辑，希望遇到个负责的，快点推进, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210908/5e1db7f0e5fe40b1aee34c6524b692af/ddf26fe993ca45ebaaeddde2fc3c64b7.jpg, createdBy=86005206116, createdName=赏你一丈红, createdTime=Thu Oct 26 09:19:08 CST 2023, time=2023-10-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1084023, encodeId=c1ac1084023c6, content=审稿速度:6.0 | 投稿命中率:25.0 | 版面费用:2950.0<br>偏重的研究方向：老年护理<br>经验分享：2021.7.14投稿，11.18更换编辑，12.5修回（4位审稿人：一位endorsed，一位reject，一位大修，一位小修），12.21修改稿上传，3位endorsed，1位reject，12.24接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5692110322, createdName=1521f88033m, createdTime=Fri Dec 24 20:46:18 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158054, encodeId=0e172158054db, content=为啥我投了之后 送审2个专家 第1个直接拒稿 第2个给了意见 返修后同意 又送审第3个专家 修稿后同意 现在又显示第4个外审专家啊 啥时候是个头哦，有前辈碰到过吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10fa6477215, createdName=ms8000000901131773, createdTime=Sat Sep 16 22:12:30 CST 2023, time=2023-09-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1055376, encodeId=829210553e6e4, content=请问一下这个杂志要找几个审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210927/5a9862d841f546cc85e85b47339bb199/f0e9ff7632ac408aac70eca0d475545a.jpg, createdBy=c0472529402, createdName=124fad42m35暂无昵称, createdTime=Mon Sep 27 15:07:53 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095352, encodeId=d013209535251, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：肺内科<br>经验分享：还在投稿，期待后续, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c98c5209159, createdName=1475736bm89暂无昵称, createdTime=Sat Oct 22 11:49:11 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223091, encodeId=432e122309135, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：临床<br>经验分享：挺快的，两个审稿人，一个接收，一个大修，修改中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f138180290, createdName=ms5000000814037832, createdTime=Sun May 29 07:53:58 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242200, encodeId=39f512422006d, content=偏重的研究方向：急危重症<br>经验分享：如果临床文章还纠结预警的话有点装了，说白了，大部分人根本就看不明白临床文章好坏跟错误，都是别人说好那就好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/yuhpYSG8zXWk7duFmickGZKMEsQE40icza3PyJ9XhHTI9Y5WmMdd8NzMNBiajBiaqcCCufuVhjErdtcMBGTuxP2OeQ/132, createdBy=01c72032081, createdName=形而上学, createdTime=Wed Aug 31 08:02:36 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236183, encodeId=018d123618327, content=审稿速度:24.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤<br>经验分享：一个多月了，还没有分配编辑，还让推荐编辑，推荐了半个月了还是没有分配编辑，你们也这么慢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da711654246, createdName=实验小达人, createdTime=Tue Aug 02 17:18:19 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235778, encodeId=c17e1235e7860, content=1个月了还没有分配编辑正常嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba715436134, createdName=ms1000001601271803, createdTime=Sun Jul 31 16:14:20 CST 2022, time=2022-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080458, encodeId=37a41080458a2, content=这个杂志是JCR Q1分区的。值得投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f4d1979640, createdName=毛教授, createdTime=Wed Dec 15 22:26:37 CST 2021, time=2021-12-15, status=1, ipAttribution=)]
    2022-05-29 ms5000000814037832

    审稿速度:1.0 | 投稿命中率:75.0
    偏重的研究方向：临床
    经验分享：挺快的，两个审稿人，一个接收，一个大修，修改中

    4

    展开4条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2164985, encodeId=887d2164985f4, content=是真的慢啊，一个多月初审审查，现在还没分配编辑，希望遇到个负责的，快点推进, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210908/5e1db7f0e5fe40b1aee34c6524b692af/ddf26fe993ca45ebaaeddde2fc3c64b7.jpg, createdBy=86005206116, createdName=赏你一丈红, createdTime=Thu Oct 26 09:19:08 CST 2023, time=2023-10-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1084023, encodeId=c1ac1084023c6, content=审稿速度:6.0 | 投稿命中率:25.0 | 版面费用:2950.0<br>偏重的研究方向：老年护理<br>经验分享：2021.7.14投稿，11.18更换编辑，12.5修回（4位审稿人：一位endorsed，一位reject，一位大修，一位小修），12.21修改稿上传，3位endorsed，1位reject，12.24接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5692110322, createdName=1521f88033m, createdTime=Fri Dec 24 20:46:18 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158054, encodeId=0e172158054db, content=为啥我投了之后 送审2个专家 第1个直接拒稿 第2个给了意见 返修后同意 又送审第3个专家 修稿后同意 现在又显示第4个外审专家啊 啥时候是个头哦，有前辈碰到过吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10fa6477215, createdName=ms8000000901131773, createdTime=Sat Sep 16 22:12:30 CST 2023, time=2023-09-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1055376, encodeId=829210553e6e4, content=请问一下这个杂志要找几个审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210927/5a9862d841f546cc85e85b47339bb199/f0e9ff7632ac408aac70eca0d475545a.jpg, createdBy=c0472529402, createdName=124fad42m35暂无昵称, createdTime=Mon Sep 27 15:07:53 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095352, encodeId=d013209535251, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：肺内科<br>经验分享：还在投稿，期待后续, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c98c5209159, createdName=1475736bm89暂无昵称, createdTime=Sat Oct 22 11:49:11 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223091, encodeId=432e122309135, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：临床<br>经验分享：挺快的，两个审稿人，一个接收，一个大修，修改中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f138180290, createdName=ms5000000814037832, createdTime=Sun May 29 07:53:58 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242200, encodeId=39f512422006d, content=偏重的研究方向：急危重症<br>经验分享：如果临床文章还纠结预警的话有点装了，说白了，大部分人根本就看不明白临床文章好坏跟错误，都是别人说好那就好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/yuhpYSG8zXWk7duFmickGZKMEsQE40icza3PyJ9XhHTI9Y5WmMdd8NzMNBiajBiaqcCCufuVhjErdtcMBGTuxP2OeQ/132, createdBy=01c72032081, createdName=形而上学, createdTime=Wed Aug 31 08:02:36 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236183, encodeId=018d123618327, content=审稿速度:24.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤<br>经验分享：一个多月了，还没有分配编辑，还让推荐编辑，推荐了半个月了还是没有分配编辑，你们也这么慢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da711654246, createdName=实验小达人, createdTime=Tue Aug 02 17:18:19 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235778, encodeId=c17e1235e7860, content=1个月了还没有分配编辑正常嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba715436134, createdName=ms1000001601271803, createdTime=Sun Jul 31 16:14:20 CST 2022, time=2022-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080458, encodeId=37a41080458a2, content=这个杂志是JCR Q1分区的。值得投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f4d1979640, createdName=毛教授, createdTime=Wed Dec 15 22:26:37 CST 2021, time=2021-12-15, status=1, ipAttribution=)]
    2022-08-31 形而上学

    偏重的研究方向：急危重症
    经验分享：如果临床文章还纠结预警的话有点装了，说白了，大部分人根本就看不明白临床文章好坏跟错误，都是别人说好那就好。

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2164985, encodeId=887d2164985f4, content=是真的慢啊，一个多月初审审查，现在还没分配编辑，希望遇到个负责的，快点推进, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210908/5e1db7f0e5fe40b1aee34c6524b692af/ddf26fe993ca45ebaaeddde2fc3c64b7.jpg, createdBy=86005206116, createdName=赏你一丈红, createdTime=Thu Oct 26 09:19:08 CST 2023, time=2023-10-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1084023, encodeId=c1ac1084023c6, content=审稿速度:6.0 | 投稿命中率:25.0 | 版面费用:2950.0<br>偏重的研究方向：老年护理<br>经验分享：2021.7.14投稿，11.18更换编辑，12.5修回（4位审稿人：一位endorsed，一位reject，一位大修，一位小修），12.21修改稿上传，3位endorsed，1位reject，12.24接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5692110322, createdName=1521f88033m, createdTime=Fri Dec 24 20:46:18 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158054, encodeId=0e172158054db, content=为啥我投了之后 送审2个专家 第1个直接拒稿 第2个给了意见 返修后同意 又送审第3个专家 修稿后同意 现在又显示第4个外审专家啊 啥时候是个头哦，有前辈碰到过吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10fa6477215, createdName=ms8000000901131773, createdTime=Sat Sep 16 22:12:30 CST 2023, time=2023-09-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1055376, encodeId=829210553e6e4, content=请问一下这个杂志要找几个审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210927/5a9862d841f546cc85e85b47339bb199/f0e9ff7632ac408aac70eca0d475545a.jpg, createdBy=c0472529402, createdName=124fad42m35暂无昵称, createdTime=Mon Sep 27 15:07:53 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095352, encodeId=d013209535251, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：肺内科<br>经验分享：还在投稿，期待后续, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c98c5209159, createdName=1475736bm89暂无昵称, createdTime=Sat Oct 22 11:49:11 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223091, encodeId=432e122309135, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：临床<br>经验分享：挺快的，两个审稿人，一个接收，一个大修，修改中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f138180290, createdName=ms5000000814037832, createdTime=Sun May 29 07:53:58 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242200, encodeId=39f512422006d, content=偏重的研究方向：急危重症<br>经验分享：如果临床文章还纠结预警的话有点装了，说白了，大部分人根本就看不明白临床文章好坏跟错误，都是别人说好那就好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/yuhpYSG8zXWk7duFmickGZKMEsQE40icza3PyJ9XhHTI9Y5WmMdd8NzMNBiajBiaqcCCufuVhjErdtcMBGTuxP2OeQ/132, createdBy=01c72032081, createdName=形而上学, createdTime=Wed Aug 31 08:02:36 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236183, encodeId=018d123618327, content=审稿速度:24.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤<br>经验分享：一个多月了，还没有分配编辑，还让推荐编辑，推荐了半个月了还是没有分配编辑，你们也这么慢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da711654246, createdName=实验小达人, createdTime=Tue Aug 02 17:18:19 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235778, encodeId=c17e1235e7860, content=1个月了还没有分配编辑正常嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba715436134, createdName=ms1000001601271803, createdTime=Sun Jul 31 16:14:20 CST 2022, time=2022-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080458, encodeId=37a41080458a2, content=这个杂志是JCR Q1分区的。值得投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f4d1979640, createdName=毛教授, createdTime=Wed Dec 15 22:26:37 CST 2021, time=2021-12-15, status=1, ipAttribution=)]
    2022-08-02 实验小达人

    审稿速度:24.0 | 投稿命中率:25.0
    偏重的研究方向：肿瘤
    经验分享：一个多月了，还没有分配编辑，还让推荐编辑，推荐了半个月了还是没有分配编辑，你们也这么慢吗

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2164985, encodeId=887d2164985f4, content=是真的慢啊，一个多月初审审查，现在还没分配编辑，希望遇到个负责的，快点推进, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210908/5e1db7f0e5fe40b1aee34c6524b692af/ddf26fe993ca45ebaaeddde2fc3c64b7.jpg, createdBy=86005206116, createdName=赏你一丈红, createdTime=Thu Oct 26 09:19:08 CST 2023, time=2023-10-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1084023, encodeId=c1ac1084023c6, content=审稿速度:6.0 | 投稿命中率:25.0 | 版面费用:2950.0<br>偏重的研究方向：老年护理<br>经验分享：2021.7.14投稿，11.18更换编辑，12.5修回（4位审稿人：一位endorsed，一位reject，一位大修，一位小修），12.21修改稿上传，3位endorsed，1位reject，12.24接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5692110322, createdName=1521f88033m, createdTime=Fri Dec 24 20:46:18 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158054, encodeId=0e172158054db, content=为啥我投了之后 送审2个专家 第1个直接拒稿 第2个给了意见 返修后同意 又送审第3个专家 修稿后同意 现在又显示第4个外审专家啊 啥时候是个头哦，有前辈碰到过吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10fa6477215, createdName=ms8000000901131773, createdTime=Sat Sep 16 22:12:30 CST 2023, time=2023-09-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1055376, encodeId=829210553e6e4, content=请问一下这个杂志要找几个审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210927/5a9862d841f546cc85e85b47339bb199/f0e9ff7632ac408aac70eca0d475545a.jpg, createdBy=c0472529402, createdName=124fad42m35暂无昵称, createdTime=Mon Sep 27 15:07:53 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095352, encodeId=d013209535251, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：肺内科<br>经验分享：还在投稿，期待后续, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c98c5209159, createdName=1475736bm89暂无昵称, createdTime=Sat Oct 22 11:49:11 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223091, encodeId=432e122309135, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：临床<br>经验分享：挺快的，两个审稿人，一个接收，一个大修，修改中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f138180290, createdName=ms5000000814037832, createdTime=Sun May 29 07:53:58 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242200, encodeId=39f512422006d, content=偏重的研究方向：急危重症<br>经验分享：如果临床文章还纠结预警的话有点装了，说白了，大部分人根本就看不明白临床文章好坏跟错误，都是别人说好那就好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/yuhpYSG8zXWk7duFmickGZKMEsQE40icza3PyJ9XhHTI9Y5WmMdd8NzMNBiajBiaqcCCufuVhjErdtcMBGTuxP2OeQ/132, createdBy=01c72032081, createdName=形而上学, createdTime=Wed Aug 31 08:02:36 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236183, encodeId=018d123618327, content=审稿速度:24.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤<br>经验分享：一个多月了，还没有分配编辑，还让推荐编辑，推荐了半个月了还是没有分配编辑，你们也这么慢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da711654246, createdName=实验小达人, createdTime=Tue Aug 02 17:18:19 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235778, encodeId=c17e1235e7860, content=1个月了还没有分配编辑正常嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba715436134, createdName=ms1000001601271803, createdTime=Sun Jul 31 16:14:20 CST 2022, time=2022-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080458, encodeId=37a41080458a2, content=这个杂志是JCR Q1分区的。值得投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f4d1979640, createdName=毛教授, createdTime=Wed Dec 15 22:26:37 CST 2021, time=2021-12-15, status=1, ipAttribution=)]
    2022-07-31 ms1000001601271803

    1个月了还没有分配编辑正常嘛

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2164985, encodeId=887d2164985f4, content=是真的慢啊，一个多月初审审查，现在还没分配编辑，希望遇到个负责的，快点推进, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210908/5e1db7f0e5fe40b1aee34c6524b692af/ddf26fe993ca45ebaaeddde2fc3c64b7.jpg, createdBy=86005206116, createdName=赏你一丈红, createdTime=Thu Oct 26 09:19:08 CST 2023, time=2023-10-26, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1084023, encodeId=c1ac1084023c6, content=审稿速度:6.0 | 投稿命中率:25.0 | 版面费用:2950.0<br>偏重的研究方向：老年护理<br>经验分享：2021.7.14投稿，11.18更换编辑，12.5修回（4位审稿人：一位endorsed，一位reject，一位大修，一位小修），12.21修改稿上传，3位endorsed，1位reject，12.24接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5692110322, createdName=1521f88033m, createdTime=Fri Dec 24 20:46:18 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158054, encodeId=0e172158054db, content=为啥我投了之后 送审2个专家 第1个直接拒稿 第2个给了意见 返修后同意 又送审第3个专家 修稿后同意 现在又显示第4个外审专家啊 啥时候是个头哦，有前辈碰到过吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10fa6477215, createdName=ms8000000901131773, createdTime=Sat Sep 16 22:12:30 CST 2023, time=2023-09-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1055376, encodeId=829210553e6e4, content=请问一下这个杂志要找几个审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210927/5a9862d841f546cc85e85b47339bb199/f0e9ff7632ac408aac70eca0d475545a.jpg, createdBy=c0472529402, createdName=124fad42m35暂无昵称, createdTime=Mon Sep 27 15:07:53 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095352, encodeId=d013209535251, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：肺内科<br>经验分享：还在投稿，期待后续, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c98c5209159, createdName=1475736bm89暂无昵称, createdTime=Sat Oct 22 11:49:11 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223091, encodeId=432e122309135, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：临床<br>经验分享：挺快的，两个审稿人，一个接收，一个大修，修改中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f138180290, createdName=ms5000000814037832, createdTime=Sun May 29 07:53:58 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242200, encodeId=39f512422006d, content=偏重的研究方向：急危重症<br>经验分享：如果临床文章还纠结预警的话有点装了，说白了，大部分人根本就看不明白临床文章好坏跟错误，都是别人说好那就好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/yuhpYSG8zXWk7duFmickGZKMEsQE40icza3PyJ9XhHTI9Y5WmMdd8NzMNBiajBiaqcCCufuVhjErdtcMBGTuxP2OeQ/132, createdBy=01c72032081, createdName=形而上学, createdTime=Wed Aug 31 08:02:36 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236183, encodeId=018d123618327, content=审稿速度:24.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤<br>经验分享：一个多月了，还没有分配编辑，还让推荐编辑，推荐了半个月了还是没有分配编辑，你们也这么慢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da711654246, createdName=实验小达人, createdTime=Tue Aug 02 17:18:19 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235778, encodeId=c17e1235e7860, content=1个月了还没有分配编辑正常嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba715436134, createdName=ms1000001601271803, createdTime=Sun Jul 31 16:14:20 CST 2022, time=2022-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080458, encodeId=37a41080458a2, content=这个杂志是JCR Q1分区的。值得投稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f4d1979640, createdName=毛教授, createdTime=Wed Dec 15 22:26:37 CST 2021, time=2021-12-15, status=1, ipAttribution=)]
    2021-12-15 毛教授

    这个杂志是JCR Q1分区的。值得投稿。

    2

    展开2条回复
共234条页码: 2/24页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分